Addex Therapeutics News - ADXN

Company Name	Stock Ticker Symbol	Market	Type
Addex Therapeutics Ltd	ADXN	NASDAQ	Depository Receipt

	Price Change	Change Percent	Stock Price	Last Traded
	-0.91	-4.34%	20.05	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
20.72	17.00	20.72	20.05	20.96

more quote information »

Recent News

Date	Time	Source	Heading
4/19/2024	01:00	GLOBE	Addex to Present at the Swiss Biotech Day 2024
4/18/2024	01:00	GLOBE	Addex Therapeutics Reports Full Year 2023 Financial Results..
4/11/2024	01:00	GLOBE	Addex Therapeutics to Release Full-Year 2023 Financial..
4/03/2024	01:00	GLOBE	Addex and Perceptive Launch Neurosterix with $63 Million to..
3/14/2024	02:00	GLOBE	Addex to Present at the Bio-Europe Spring 2024 Conference
1/31/2024	01:00	GLOBE	Addex Enters into At-The-Market ADS Offering Agreement with..
1/30/2024	17:00	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/30/2024	16:58	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/09/2024	01:00	GLOBE	Addex to Present at the Swiss Equities Baader Conference
1/05/2024	01:30	GLOBE	Addex to Present at Biotech Showcase™ 2024
12/21/2023	06:00	EDGAR2	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
12/20/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/2023	01:00	GLOBE	Addex Shareholders Approve All Resolutions at Extraordinary..
12/14/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/2023	01:00	GLOBE	Addex Creates Treasury Shares
12/08/2023	14:11	EDGAR2	Form SC 13D/A - General statement of acquisition of..
11/30/2023	16:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/30/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/29/2023	16:00	EDGAR2	Form SC 13D/A - General statement of acquisition of..
11/29/2023	06:27	EDGAR2	Form POS AM - Post-Effective amendments for registration..
11/29/2023	06:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/2023	01:00	GLOBE	Addex Reports Q3 2023 Financial Results and Provides..
11/28/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/28/2023	01:00	GLOBE	Addex Convenes Extraordinary General Meeting
11/23/2023	01:00	GLOBE	Addex Therapeutics to Release Third Quarter 2023 Financial..
11/14/2023	01:00	GLOBE	Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
11/08/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/08/2023	01:00	GLOBE	Addex Regains Nasdaq Listing Compliance
11/02/2023	02:00	GLOBE	Addex Announces Participation in the Bio-Europe 2023..
10/23/2023	06:01	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/20/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/20/2023	01:00	GLOBE	Addex Completes ADS Ratio Change
10/06/2023	16:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/06/2023	16:00	GLOBE	Addex Announces Plan to Implement ADS Ratio Change
9/20/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/20/2023	01:00	GLOBE	Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
9/06/2023	01:00	GLOBE	Addex Announces Participation in the H.C. Wainwright 25th..
9/05/2023	06:10	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/2023	06:10	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/2023	01:00	GLOBE	Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
9/04/2023	01:00	GLOBE	Addex’s Dipraglurant Development in Post-Stroke Recovery..
8/11/2023	16:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/10/2023	16:00	EDGAR2	Form POS AM - Post-Effective amendments for registration..
8/10/2023	06:31	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/10/2023	01:00	GLOBE	Addex Reports 2023 Half Year and Second Quarter Financial..
8/04/2023	01:00	GLOBE	Addex Therapeutics to Release Half-Year 2023 Financial..
8/03/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/03/2023	01:00	GLOBE	Addex GABAB Positive Allosteric Modulator Program to Receive..
7/24/2023	06:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/24/2023	01:00	GLOBE	Addex mGlu2PAM Demonstrates Potential in Substance Use..